Alexander Gerbes
Overview
Explore the profile of Alexander Gerbes including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
42
Citations
3889
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Fernandez J, Prado V, Trebicka J, Amoros A, Gustot T, Wiest R, et al.
J Hepatol
. 2018 Nov;
70(3):398-411.
PMID: 30391380
Background & Aims: Antibiotic resistance has been increasingly reported in patients with decompensated cirrhosis in single-center studies. Prospective investigations reporting broad epidemiological data are scarce. We aimed to analyze epidemiological...
22.
Ardelt M, Frohlich T, Martini E, Muller M, Kanitz V, Atzberger C, et al.
Hepatology
. 2018 Jul;
69(1):376-393.
PMID: 30033593
Therapeutic options for patients with advanced-stage hepatocellular carcinoma (HCC) are very limited. The only approved first-line treatment is the multi-tyrosine kinase inhibitor sorafenib, which shows low response rates and severe...
23.
Englschalk C, Eser D, Jox R, Gerbes A, Frey L, Dubay D, et al.
BMC Med Ethics
. 2018 Feb;
19(1):7.
PMID: 29433496
Background: The allocation of any scarce health care resource, especially a lifesaving resource, can create profound ethical and legal challenges. Liver transplant allocation currently is based upon urgency, a sickest-first...
24.
Piano S, Schmidt H, Ariza X, Amoros A, Romano A, Husing-Kabar A, et al.
Clin Gastroenterol Hepatol
. 2018 Feb;
16(11):1792-1800.e3.
PMID: 29391267
Background & Aims: Type 1 hepatorenal syndrome (HRS) is the most high-risk type of renal failure in patients with cirrhosis. Terlipressin and albumin are effective treatments for type 1 HRS....
25.
Gerbes A, Zoulim F, Tilg H, Dufour J, Bruix J, Paradis V, et al.
Gut
. 2017 Nov;
67(2):380-388.
PMID: 29150490
Hepatocellular carcinoma (HCC) ranks number three among the most frequent causes of death from solid tumors worldwide. With obesity and fatty liver diseases as risk factors on the rise, HCC...
26.
Munch S, Habermehl D, Agha A, Belka C, Combs S, Eckel R, et al.
Strahlenther Onkol
. 2017 Oct;
194(2):125-135.
PMID: 29071366
Background: To date, it remains unclear whether locally advanced adenocarcinoma of the gastroesophageal junction (AEG) should be treated with neoadjuvant chemoradiation (nCRT), analogous to esophageal cancer, or with perioperative chemotherapy...
27.
Busk T, Moller S, Pedersen E, Gerbes A, Krag A, Peck-Radosavljevic M, et al.
J Gastroenterol Hepatol
. 2017 Jan;
32(5):1087-1093.
PMID: 28092112
Background And Aim: Urinary aquaporin-2 (AQP2) is a parameter of water transport in the principal cells in the distal part of the nephron and involved in water retention in cirrhosis...
28.
Claria J, Stauber R, Coenraad M, Moreau R, Jalan R, Pavesi M, et al.
Hepatology
. 2016 Aug;
64(4):1249-64.
PMID: 27483394
Unlabelled: Acute-on-chronic liver failure (ACLF) in cirrhosis is characterized by acute decompensation (AD), organ failure(s), and high short-term mortality. Recently, we have proposed (systemic inflammation [SI] hypothesis) that ACLF is...
29.
Andrassy J, Wolf S, Hoffmann V, Rentsch M, Stangl M, Thomas M, et al.
Langenbecks Arch Surg
. 2016 Mar;
401(3):389-96.
PMID: 26960592
Purpose: Postoperative complications may have not only immediate but also long-term effects on the outcomes. Here, we analyzed the effect of postoperative complications requiring a reoperation (grade 3b) within the...
30.
Khandoga A, Iskandarov E, Angele M, Gerbes A, Frey L, Agayev B, et al.
Eur J Gastroenterol Hepatol
. 2015 Nov;
28(2):153-8.
PMID: 26545081
Background: Early allograft dysfunction after liver transplantation (LTX) is not well defined. The aim of this study was to evaluate the value of early post-transplant model for end-stage liver disease...